The Promise and Perils of Diversity Action Plans for Clinical TrialsJAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATIONIF552024-12-030PRE
Ranking pharmaceutical companies on clinical trial diversityBMJ-BRITISH MEDICAL JOURNALIF42.72023-02-101OA
Metrics, baseline scores, and a tool to improve sponsor performance on clinical trial diversity: retrospective cross sectional study指标、基线评分和提高临床试验多样性申办者绩效的工具: 回顾性横断面研究BMJ MEDICINEIF102023-01-0520OAAI
Physician-Legislators in Federal and State Government in 2022JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATIONIF552022-12-273OA
Diversity in clinical research: public health and social justice imperativesJOURNAL OF MEDICAL ETHICSIF3.42022-04-1527PRE
Reporting of Study Participant Demographic Characteristics and Demographic Representation in Premarketing and Postmarketing Studies of Novel Cancer TherapeuticsJAMA NETWORK OPENIF9.72021-04-2032OAAI
Equitable Access to Research Benefits: Considerations for COVID-19 Vaccine Development and Clinical Trial CrossoverAMERICAN JOURNAL OF BIOETHICSIF20.82021-02-223PREAI
Determining the willingness to pay for ecosystem service restoration in a degraded coastal watershed: A ninth grade investigation确定退化的沿海流域为生态系统服务恢复付费的意愿: 九级调查ECOLOGICAL ECONOMICSIF6.32014-08-0133PREAI